GDNF protects enteric glia from apoptosis: evidence for an autocrine loop by Steinkamp, Martin et al.
GDNF protects enteric glia from apoptosis:
evidence for an autocrine loop
Steinkamp et al.
Steinkamp et al. BMC Gastroenterology 2012, 12:6
http://www.biomedcentral.com/1471-230X/12/6 (17 January 2012)RESEARCH ARTICLE Open Access
GDNF protects enteric glia from apoptosis:
evidence for an autocrine loop
Martin Steinkamp
1, Heike Gundel
2, Nadine Schulte
2, Ulrike Spaniol
2, Carolin Pflueger
2, Eugen Zizer
2 and
Georg BT von Boyen
2*
Abstract
Background: Enteric glia cells (EGC) play an important role in the maintenance of intestinal mucosa integrity.
During the course of acute Crohn’s disease (CD), mucosal EGC progressively undergo apoptosis, though the
mechanisms are largely unknown. We investigated the role of Glial-derived neurotrophic factor (GDNF) in the
regulation of EGC apoptosis.
Methods: GDNF expression and EGC apoptosis were determined by immunofluorescence using specimen from CD
patients. In primary rat EGC cultures, GDNF receptors were assessed by western blot and indirect
immunofluorescence microscopy. Apoptosis in cultured EGC was induced by TNF-a and IFN-g, and the influence of
GDNF on apoptosis was measured upon addition of GDNF or neutralizing anti-GDNF antibody.
Results: Increased GDNF expression and Caspase 3/7 activities were detected in in specimen of CD patients but
not in healthy controls. Moreover, inactivation of GDNF sensitized in EGC cell to IFN-g/TNF-a induced apoptosis.
Conclusions: This study proposes the existence of an autocrine anti-apoptotic loop in EGC cells which is operative
in Crohn’s disease and dependent of GDNF. Alterations in this novel EGC self-protecting mechanism could lead to
a higher susceptibility towards apoptosis and thus contribute to disruption of the mucosal integrity and severity of
inflammation in CD.
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Background
In inflammatory bowel disease (IBD), the impairment of
the bowel luminal barrier function is suggested as an
important pathophysiologic mechanism that triggers
inflammatory activity of the mucosa [1-3]. The translo-
cation of luminal antigens into the mucosa perpetuates
the inflammatory response, and may contribute to the
chronification of the disease [1-5]. Therefore, the integ-
rity of the epithelial lining is essential for gut mucosal
homeostasis and integrity [6,7], and cytokines that pro-
mote antiapoptotic effects on intestinal epithelial cells
or stimulate their proliferation are suggested to be
important protective factors. Neurotrophins has been
identified as antiapoptotic substances for the colonic
epithelial cells [8,9]. The source of neurotrophins and
neurotrophic factors could be identified as the enteric
glia cells (EGC) of the mucosal plexus [10]. On the
other hand, it was shown that in Crohn’sd i s e a s e( C D )
the amount of glial cells is reduced [11,12]. This may
due to apoptotic events in the EGC, followed by a
reduced ability for maintenance of an intact mucosal
barrier function. Until now, the exact mechanisms of
interaction in this protective network remain unclear.
To date, the EGC seems to represent an ownstanding
entity of cell population, since they share some cell
properties with astroglia in the central nervous system
(CNS), but on the other hand they also exert also simi-
larities to microglia [6,7,13].
In this paper, we aimed to investigate the role of glial-
derived neurotrophic factor (GDNF) in the regulation of
EGC apoptosis.
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Human tissue
The whole research work is conformed to the Helsinki
Declaration. The patients enrolled in the study gave
their informed consent and the study was approved by
the local ethical committee of the University of Ulm,
which is leaded by Prof. Dr. U. Brückner. The diagno-
sis of CD was established by using usual criteria [14].
Inflamed colonic biopsies were taken from 10 patients
with CD (5 female/5 male; mean age 34 years; range
23 to 48 years). Biopsies were taken during colono-
scopy. The mean duration of CD was 4.5 years. No
patients received biologics. 4 CD patients were treated
with azathioprine, one patient with 6-MP and 3
patients with budesonide. The other patients were not
treated at the time of study and had only less clinical
signs of activity.
As controls healthy colonic biopsies were taken from
26 patients, which underwent a routine screening colo-
noscopy (1 female/4 male; mean age 56 years; range 51
to 60 years). Tissue GFAP, GDNF and c-Caspase-3
levels were measured by immunofluorescence. Patient
informed consent for taking and analysis of biopsy spe-
cimen was obtained. The study was approved by the
local ethics comittee.
Indirect immunofluorescence
Tissue-biopsies were deparaffinized and permeabilized
with PBS/0.3% Triton X100. Antigen retrieval was per-
formed by boiling the slides in 0.01 M trisodium
citrate buffer, pH 6, for 10 min. Sections were then
preincubated with 10% normal goat serum containing
0.2% Triton X-100 overnight at 4°C to block nonspeci-
fic binding. Slides were then incubated over night at 4°
C with Antibodies against GFAP (Pharmingen, San
Diego, USA, mouse, 1:100), GDNF (Abcam, USA, rab-
bit, 1:100) or GDNF (Sigma-Aldrich, USA, mouse,
1:80) and rabbit anticleaved caspase-3 (1:200, Cell Sig-
nalling Technology).
After washing in PBS/0,1% Tween 20, the slides were
incubated with the appropriate secondary antibodies:
cy3 coupled goat anti-mouse IgG (DPC Biermann, Bad
Nauheim, Germany) or cy3 coupled goat anti-rabbit IgG
(DPC Biermann, Bad Nauheim, Germany) and Alexa
488 coupled goat anti-rabbit IgG (Sigma) or Alexa
c o u p l e dg o a ta n t i - m o u s eI g G(Sigma). Dilutions of the
secondary antibodies were 1:800. After washing in PBS,
slides were embedded in glycerol gelatine. Control label-
ling was performed with omission of the first antibodies
to ensure that there was no unspecific labelling of cells.
Tissue-biopsies were analyzed using a Leica confocal
laser-scanning microscope. Single optical sections were
recorded under conditions, which exclude cross-activa-
tion of the individual signal channels.
Histological analysis
Every three Immunolabelled biopsies of 10 CD and 5
control persons were used for evaluating the expression
of GFAP, GDNF and cCaspase-3 in EGCs.
Dissociated EGC cultures
Newborn rats (Wistar strain) were decapitated. The
intestines were removed and the myenteric plexus was
isolated as previously described (21). In brief, small
intestines were rinsed in sterile MEM with 25 mM
HEPES buffer (Gibco Life Technologies, California
USA). The muscle layer containing the myenteric plexus
was stripped from the mucosa. The tissue was incubated
in a collagenase solution (CL type II, Gibco, 1 mg/ml)
in Hanks balanced salt solution (Gibco) for 1.5 h at 37°
C. The disintegrated tissue was vortexed and the iso-
lated parts of the myenteric plexus were stored in MEM
on ice. The collected pieces were incubated in trypsin
(0.1 mg/ml, Gibco) for 15 min at 37°C and then centri-
fuged. Trypsinisation was stopped by addition of fetal
calf serum (Gibco). Then cells were plated on polyor-
nithine coated (0.5 mg/ml, Sigma, Schnelldorf, Ger-
many) coverslips and were topped with 450 μlD M E M -
F-12 (Gibco). The cultures were kept in a humidified
atmosphere of 95% air/5%CO2 at 37°C. At day 3, the
culture consisted of approximately 98% of EGCs.
Indirect immunofluorescence
The EGCs of each animal were pooled and cultured on
20 different coverslips. Cell cultures were fixed and per-
meabilized with 90% methanol, 10% acetic acid cooled
down to -40°C. After washing in PBS cells were blocked
with 1% bovine serum (Sigma) for 40 min, anti-GFR-a1-
3 and Ret (Becton Dickinson Transduction, Germany,
R&D Systems, Germany, Santa Cruz, Germany) antibo-
dies were incubated for 1 h at room temperature.
Immunofluorescence staining was done by secondary
antibodies: goat anti-mouse IgG (cy3, Sigma) or rabbit
anti-goat (cy3, Becton Dickinson, Transduction, Ger-
many). After immunostaining, coverslips were mounted
cell side down on microscope slides using moviol. Cell
cultures were analyzed using a Leica confocal laser-scan-
ning microscope.
Apoptosis in EGC cultures induced by tumor necrosis
factor-a and interferon-g
Rat primary enteric glia was isolated as described above.
For induction of apoptosis, the glia was seeded in 48
well plates. After reaching confluence, the cells were
washed twice with PBS, and thereafter 180 μl Dulbecco’s
minimal essential medium (DMEM) was added, contain-
ing 100 ng/ml interferon-g,1 0 0n g / m lT N F - a, both or
carrier. Then, the cultures were incubated with or with-
out GDNF 100 ng/ml, or carrier over a period of 40
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against GDNF, the cells were preincubated for 1 hour
with anti-GDNF 0,5 μg/ml. For detection of caspase 3/7
activity in the ECG cultures, the caspase substrate Rho-
damin 110 was added in the relation 1:1 to the wells
according to the instructions of the manufacturer of the
assay (ApoOne Homogenous caspase 3/7 Assay, Pro-
mega, Germany), and the wells were vortexed at room
temperature over 2 minutes at 400 rpm. After additional
2 hours at room temperature, the wells were vortexed
again, followed by fluorometric measurement of the cas-
pase 3/7 activity according to the manufacturers recom-
mendations. In brief, the stimulation wavelength was
485/20, the emission wavelength was 528/20. Three
independent experiments were performed in duplicates,
the results are indicated as mean values ± SD.
Western blot analysis of GDNF receptors in primary
enteric rat glia
Western blot analysis was performed according to stan-
dard protocols as described elsewhere [12]. In brief, pri-
mary enteric rat glia was seeded in 10 cm diameter
culture dishes, and after reaching confluence rinsed with
PBS three times. Thereafter, the cells were lysed and
prepared as described before [12]. The antibodies for
the detection of GFR-a1-3 and Ret was purchased from
R&D Systems, Germany. For western blotting, it was
used at a concentration of 1:25.
Data analysis
All data given in the text and figures are expressed as
mean values ± SEM. The data were analyzed using non-
parametric two-tailed Mann-Whitney U test with p ≤
0.05 considered as an indicator of significance.
Results
GDNF regulation and caspase 3 activation in EGC of
patients with CD
In biopsy specimen of patients suffering from CD, caspase
3 activation could be detected in the mucosal glial plexus,
and this was coincident to GFAP and to GDNF expression
in the same structures. In controls, neither caspase 3 acti-
vation nor GFAP or GNDF upregulation was recognized
(Figure 1). These results suggest the occurence of apopto-
sis in the mucosal plexus and GDNF upregulation in the
context of chronic bowel inflammation.
GDNF receptor expression in rat primary EGC cultures
The expression of the GDNF receptors GFR-a1, GFR-
a2, GFR-a3 and the coreceptor Ret was determined
from lysates of EGC cultures using western blot. We
were able to detect specific bands for all GDNF recep-
tors (Figure 2). Furthermore, we performed an indirect
immunofluorescence staining of EG cells cultures to
prove these results in a second method (Figure 3). We
confirmed our results, as all receptors were specifically
detectable in this second method. The blots are pre-
sented to confirm the presence of the receptors, but not
the quantity or different expression levels. Therefore, a
GAPDH control is omitted.
TNF-a and IFN-g induces apoptosis in EGC, influence of
GDNF and anti-GDNF
Since glial cells are assumed as highly apoptosis resistant
cells, we aimed to expose these cells to an inflammatory
cytokine environment using TNF-a and IFN-g. Neither
of these factors alone was able to induce apoptosis in
primary rat EGC cultures, but in combination they sig-
nificantly increased apoptosis rates in the cultures by
nearly 2 fold, as indicated by a caspase 3/7 activation in
these cells. Noteworthy, we have also tested various
other combinations of important cytokines with implica-
tion in Crohn’s disease (e.g. IL-1ß, IL-6) but failed to
induce apoptosis (data not shown). The addition of
GDNF had no effect on the apoptosis rate in the cell
cultures, but it was also not able to alter the apoptosis
rate in the cultures after induction of apoptosis by the
combination of TNF-a and IFN-g (Figure 4). However,
if a neutralizing antibody against GDNF was added to
neutralize endogenous secreted GDNF, the apoptosis
rates in the cultures that were stimulated with TNF-a
and IFN-g raised significantly (Figure 5). Therefore, it is
likely that an autocrine antiapoptotic loop is activated in
EGC when exposed to inflammatory conditions.
Discussion
Recent molecular and biochem i c a la n a l y s i sa sw e l la s
cell biology approaches demonstrated important regula-
tory functions of mucosal EGC in the assembly and
maintenance of intestinal mucosa integrity [9,10]. This
is underscored by the potential of EGC to secrete key
c y t o k i n e sa n dg r o w t hf a c t o r ss u c ha si n t e r l e u k i n - 6( I L -
6), and TGF-ß1 [15,16], which ensure cell communica-
tion with the microenvironment. EGC thereby influence
local immune responses and control vital cellular func-
tions including differentiation, growth and survival.
Consistent with the capacity of EGC cells to control sur-
vival and cell death, we have most recently shown that
GDNF, when expressed and secreted from primary rat
enteric glia cells, can protect epithelial cells from apop-
tosis [9]. It is therefore not surprising that reduced EGC
levels, as frequently found in active Crohn’sd i s e a s eo r
following different experimental settings in mice, result
in disrupted mucosa integrity with increased inflamma-
tion and acquisition of hemorrhagic lesions [11,17].
Interestingly, however, the underlying molecular
mechanisms of how EGC protect themselves from cyto-
kine mediated apoptosis remained elusive.
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G,J red) and cCaspase-3 (B,E green) or anti GDNF (H,K green) antibodies and were analyzed by optical sectioning using a confocal
microscope. Both antigens, GFAP (A) and c-Caspase-3 (B) can be detected highly in the intestinal wall of the inflamed colon of CD (A,B). The
merged images (C) reveal an almost complete overlap of both immunoreactivities (yellow). Only few GFAP-positive cells (D) display no cCaspase-
3 immunoreactivity (E) in the control section (F). Although a high immunoreactivity of GDNF (H) in GFAP-positive cells (G,I) and in the epithelial
cells of biopsies of patients with CD can be detected, in control biopsies GFAP-positive EGCs (J), which are positioned in the mucosal plexus in
close vicinity to the epithelium of the colon, show no GDNF secretion (K,L). Furthermore the subepithelial cells, which express GDNF highly (N,
green) showed a colocalization with cCaspase-3 in sections of CD (M-O), whereas in controls no relevant apotosis, proofed by cCaspase-3, or
GDNF expression could be detected (P-R). Scale bars, 50 um.
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regulatory loop which allows EGC cells to escape from
cell death. We show for the first time that GDNF, which
is produced and secreted by EGC cells feeds back in an
autocrine manner to protect EGC from apoptosis, thus
contributing to integrity of the mucosal EGC plexus.
We have identified high level of GDNF expression in
mucosal EGC from patients with Crohn’s disease,
whereas GDNF was not detectable in healthy controls.
Interestingly, our analysis further revealed remarkable
expression of all subclasses of GDNF receptors, namely
GFR-a1-3, and the coreceptor Ret in primary EGCs,
indicating that EGC themselves may be target cells for
secreted GDNF under inflammatory conditions. To test
this hypothesis, we decided to challenge EGC cultures
with TNF-a and IFN-g, two major apoptosis related
cytokines whith key functions in Crohn’s disease.
Neither TNF-a nor IFN-g alone caused a significant
effect on EGC cultures with respect to cell death, thus
supporting a previously suspected relative insensitivity
of EGC to apoptosis. However when both cytokines
were combined, we observed a significant increase in
apoptosis, as measured by caspase 3/7 activation. Even
more important, however, induction of apoptosis by
TNF-a/IFN-g was further and most dramatically
increased upon inactivation of GDNF. These findings
not only underscore the relevance of GDNF in regula-
tion of EGC cells but also emphasize a so far unknown
cell protective and anti-apoptotic function.
Figure 2 Detection of the receptors GFR-a 1-3 and Ret
receptor by Western Blot. The molecular weight (kDa) of the
protein are shown on the right of the western blot figures. These
blots are representative of 3 independent experiments (N = 3).
Figure 3 Detection of GFR-a 1 (A) -2 (B) -3 (C) and Ret receptor (D) in primary EGC culture by Indirect immunofluorescence.( E )
Negative control under omission of first antibody. Magnification: 20fold. These stains are representative of 3 independent experiments (N = 3).
Figure 4 Activation of caspase 3/7 in primary EGC cultures.
Fluorometric detection of caspase 3/7 activity after incubation of
the EGC cultures with TNF-a (100 ng/ml), IFN-g (100 ng/ml) and
GDNF (100 ng/ml), alone or in combination as described above. The
bars indicate mean values ± SD, normalized to controls, three
independent experiments were performed in duplicates (N = 3).
Asterisk indicates a significant increase as compared to controls
(p < 0.05).
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express all receptors for GDNF and in addition, produce
high amounts of GDNF in bowel inflammation [10],
these results allow us to hypothesize the existence of an
autocrine loop that prevents EGC from apoptosis. More-
over, disruption of this novel regulatory mechanism by
addition of a neutralizing antibody against GDNF
uncovered strong antiapoptotic effects of GDNF, which
might have important implications in the preservation
and maintenance of mucosal glia integrity and apoptosis
resistance.
Conclusions
Therefore, we conclude that GDNF is an important
endogenous factor for the regulation of EGC apoptosis,
a n di sp a r to fan e t w o r ko fp r o t e c t i v es u b s t a n c e st h a t
may be important for mucosal integrity and healing.
Furthermore, alterations leading to disruption of this
protective network of neurotrophins and neurotrophic
factors might contribute to a more severe course of
inflammation. The effects shown in this study focus on
Crohn’s disease. Additional studies on ulcerative colitis
are required in future approaches in order to transfer
our results to IBD in general.
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